XLO XILIO THERAPEUTICS INC Management Changes 8-K Filing 2024 - Equity Awards Granted to Executive Officers Xilio Therapeutics granted annual equity awards to its executive officers, including 177,000 restricted stock units to the CEO and 20,000 restricted stock units to the senior VP of finance and accounting.Get access to all SEC 8-K filings of the XILIO THERAPEUTICS INC